Cite
Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2).
MLA
Asher, Elad, et al. “Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2).” PLoS ONE, vol. 11, no. 6, June 2016, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0157437.
APA
Asher, E., Abu-Much, A., Goldenberg, I., Segev, A., Sabbag, A., Mazin, I., Shlezinger, M., Atar, S., Zahger, D., Polak, A., Beigel, R., Matetzky, S., & null, null. (2016). Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2). PLoS ONE, 11(6), 1–12. https://doi.org/10.1371/journal.pone.0157437
Chicago
Asher, Elad, Arsalan Abu-Much, Ilan Goldenberg, Amit Segev, Avi Sabbag, Israel Mazin, Meital Shlezinger, et al. 2016. “Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2).” PLoS ONE 11 (6): 1–12. doi:10.1371/journal.pone.0157437.